Fulminant type 1 diabetes mellitus induced by pembrolizumab in a patient with urothelial carcinoma: A case report

A case of fulminant type 1 diabetes mellitus secondary to administration of pembrolizumab in a patient with urothelial carcinoma is presented. Eight days after the third infusion of pembrolizumab, the patient presented with complaints of malaise and anorexia. The patient's laboratory data showe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Urol Case Rep
Autores principales: Tohi, Yoichiro, Fujimoto, Kanta, Suzuki, Ryosuke, Suzuki, Issei, Kubota, Masashi, Kawakita, Mutsushi
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2019
Materias:
Trauma and Reconstruction
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562295/
https://ncbi.nlm.nih.gov/pubmed/31211060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2019.100849
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares